{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:10:18Z","timestamp":1761743418860},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.juro.2010.08.088","type":"journal-article","created":{"date-parts":[[2010,11,13]],"date-time":"2010-11-13T09:22:14Z","timestamp":1289640134000},"page":"104-110","source":"Crossref","is-referenced-by-count":21,"title":["Prospective Evaluation of Operating Characteristics of Prostate Cancer Detection Biomarkers"],"prefix":"10.1097","volume":"185","author":[{"given":"Yuanyuan","family":"Liang","sequence":"first","affiliation":[{"name":"Department of Urology, University of Texas Health Science Center, San Antonio, Texas"},{"name":"Department of Epidemiology and Biostatistics, University of Texas Health Science Center, San Antonio, Texas"},{"name":"University of Texas Houston School of Public Health, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna P.","family":"Ankerst","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas Health Science Center, San Antonio, Texas"},{"name":"Department of Epidemiology and Biostatistics, University of Texas Health Science Center, San Antonio, Texas"},{"name":"Department of Mathematics, Technische Universitaet Muenchen, Muenchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norma S.","family":"Ketchum","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of Texas Health Science Center, San Antonio, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Ercole","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas Health Science Center, San Antonio, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Basic Pharmaceutical Sciences, Monroe, Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Shaughnessy","sequence":"additional","affiliation":[{"name":"Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, University of Arkansas for Medical Sciences, Little Rock, Arkansas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin J.","family":"Leach","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas Health Science Center, San Antonio, Texas"},{"name":"Department of Pediatrics, University of Texas Health Science Center, San Antonio, Texas"},{"name":"Department of Cellular and Structural Biology, University of Texas Health Science Center, San Antonio, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian M.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Texas Health Science Center, San Antonio, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2010.08.088_bib1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3322\/caac.20066","article-title":"American Cancer Society guideline for the early detection of prostate cancer: update 2010","volume":"60","author":"Wolf","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.juro.2010.08.088_bib2","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Tian","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2010.08.088_bib3","unstructured":"Shah GV, Srivastava AK and Iczkowski K: Neuroendocrine marker: a novel, reliable early stage marker for prostate cancer. Presented at the 100th annual meeting of the American Association for Cancer Research, Denver, Colorado, April 18\u201322, 2009, abstract 4826."},{"key":"10.1016\/j.juro.2010.08.088_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.294.1.66","article-title":"The operating characteristics of prostate-specific antigen in a population with initial PSA of 3.0 ng\/ml or lower","volume":"294","author":"Thompson","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2010.08.088_bib5","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/sim.4780111110","article-title":"On the sample size for studies based upon McNemar's test","volume":"11","author":"Lachenbruch","year":"1992","journal-title":"Stat Med"},{"key":"10.1016\/j.juro.2010.08.088_bib6","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.juro.2010.08.088_bib7","first-page":"6958","article-title":"A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer","volume":"61","author":"Mikolajczyk","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2010.08.088_bib8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0090-4295(01)01605-3","article-title":"Free prostate-specific antigen in serum is becoming more complex","volume":"50","author":"Mikolajczyk","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.juro.2010.08.088_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2302\/kjm.52.86","article-title":"Pro PSA: a more cancer specific form of prostate specific antigen for the early detection of prostate cancer","volume":"52","author":"Mikolajczyk","year":"2003","journal-title":"Keio J Med"},{"key":"10.1016\/j.juro.2010.08.088_bib10","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1373\/clinchem.2003.026823","article-title":"Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer","volume":"50","author":"Mikolajczyk","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.juro.2010.08.088_bib11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.clinbiochem.2004.05.016","article-title":"Are multiple markers the future of prostate cancer diagnostics?","volume":"37","author":"Mikolajczyk","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.juro.2010.08.088_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1200\/JCO.2003.02.083","article-title":"Biology of prostate-specific antigen","volume":"21","author":"Balk","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2010.08.088_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11934-004-0042-6","article-title":"Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer","volume":"5","author":"Haese","year":"2004","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.juro.2010.08.088_bib14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0302-2838(02)00179-3","article-title":"Estimation of prostate cancer risk on the basis of total and free prostate-specific antigen, prostate volume and digital rectal examination","volume":"41","author":"Finne","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.08.088_bib15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.juro.2008.04.015","article-title":"[-2]Proenzyme prostate specific antigen for prostate cancer detection: a National Cancer Institute Early Detection Research Network validation study","volume":"180","author":"Sokoll","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.08.088_bib16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/pros.20872","article-title":"A [-2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases","volume":"69","author":"Stephan","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.juro.2010.08.088_bib17","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.eururo.2010.02.003","article-title":"Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection","volume":"57","author":"Jansen","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.08.088_bib18","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1158\/1055-9965.EPI-10-0007","article-title":"A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness","volume":"19","author":"Sokoll","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.juro.2010.08.088_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.urolonc.2004.07.017","article-title":"Evaluation of precursor prostate-specific antigen isoform ratios in the detection of prostate cancer","volume":"23","author":"Naya","year":"2005","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2010.08.088_bib20","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0090-4295(02)02398-1","article-title":"Proenzyme PSA for the early detection of prostate cancer in the 2.5\u20134.0 ng\/ml total PSA range: primary analysis","volume":"1","author":"Sokoll","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.juro.2010.08.088_bib21","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1097\/01.ju.0000095460.12999.43","article-title":"Serum pro prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2 to 4 ng\/ml","volume":"170","author":"Catalona","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.08.088_bib22","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1097\/01.ju.0000127737.94221.3e","article-title":"Serum pro-prostate specific antigen preferentially detects aggressive prostate cancers in men with 2 to 4 ng\/ml prostate specific antigen","volume":"171","author":"Catalona","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.08.088_bib23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnci\/djj131","article-title":"Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial","volume":"98","author":"Thompson","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2010.08.088_bib24","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.urology.2006.10.022","article-title":"External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population","volume":"68","author":"Parekh","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.juro.2010.08.088_bib25","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.juro.2009.08.056","article-title":"Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection","volume":"182","author":"Eyre","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.08.088_bib26","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1158\/0008-5472.CAN-09-3879","article-title":"Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy","volume":"70","author":"Sato","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2010.08.088_bib27","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1158\/0008-5472.CAN-06-3369","article-title":"Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas","volume":"67","author":"Yamabuki","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2010.08.088_bib28","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/pros.20805","article-title":"Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis","volume":"68","author":"Hall","year":"2008","journal-title":"Prostate"},{"key":"10.1016\/j.juro.2010.08.088_bib29","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter","volume":"350","author":"Thompson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2010.08.088_bib30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.eururo.2009.10.031","article-title":"Eleven-year outcome of patients with prostate cancers diagnosed during screening after initial negative sextant biopsies","volume":"57","author":"Schroder","year":"2010","journal-title":"Eur Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710045295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710045295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2010.08.088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:45:51Z","timestamp":1651196751000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2010.08.088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1016\/j.juro.2010.08.088"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2010.08.088","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}